Related Experiment Videos
[Effects of synthetic peptides on ovarian cancer cells]
1Obstetrics and Gynecology Hospital, Shanghai Medical University, Shanghai 200011.
Objective:
To observe the effect of follicle-stimulating hormone(FSH) synthetic peptides(FSH binding Fragment), FSH and synthetic peptides on the proliferation of human epithelial ovarian cancer cell.
Methods:
Human epithelial ovarian cancer cells lines SKOV3, OVCAR, AO and 3AO were incubated with FSH, FSH binding fragment, FSH and the binding fragment respectively. The cell proliferation was detected by methyl thiazolyl tetrazolium (MTT) technique.
Results:
The rate of proliferation in the cancer cell was increased apparently as increasing in the concentration of FSH and the rate of proliferation average value 28.0%, and was decreased apparently as increasing in the concentration of the synthetic peptides and the rate of inhibition average value 8.3%. When the cell was expressed in FSH, the proliferation was decreased apparently as increasing in the concentration of the peptides and the rate of inhibition average valve 3.1%.
Conclusions:
It is suggested that FSH binding fragment can inhibit the proliferation of ovarian cancer cell. The FSH binding fragment could be used as a binding part of anticancerous complex for ovarian cancer.
Insights
Follicle-stimulating hormone (FSH) can increase ovarian cancer cell proliferation. However, an FSH binding fragment inhibits cancer cell growth, suggesting its potential in ovarian cancer treatment.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Context:
- Ovarian cancer is a significant global health concern.
- The role of follicle-stimulating hormone (FSH) in ovarian cancer progression is complex and warrants further investigation.
- Understanding the molecular mechanisms underlying ovarian cancer cell proliferation is crucial for developing targeted therapies.
Purpose:
- To investigate the effects of FSH and its synthetic binding fragment on the proliferation of human epithelial ovarian cancer cell lines.
- To determine if the FSH binding fragment possesses anti-proliferative properties against ovarian cancer cells.
Summary:
- Human epithelial ovarian cancer cell lines (SKOV3, OVCAR, AO, and 3AO) were treated with FSH and an FSH binding fragment.
- FSH treatment led to a significant increase in cancer cell proliferation (average 28.0%).
- Conversely, the FSH binding fragment demonstrated an inhibitory effect, reducing proliferation by an average of 8.3%, and further reducing it by 3.1% when co-applied with FSH.
Impact:
- The FSH binding fragment shows potential as an anti-cancerous agent for ovarian cancer.
- This fragment could be developed as a component of targeted therapeutic complexes for ovarian cancer treatment.
- Further research into the FSH binding fragment's mechanism of action may reveal novel therapeutic strategies.